Latest Announcements

Piramal Finance Ltd has announced the schedule of Analyst/Institutional Investor Meetings and Investor Presentation under the SEBI Listing Regulations. The meetings will be held in Hong Kong and Singapore, and the presentation will be made at the conference. The company has also released its Q1 FY27 results, showing growth in AUM and profit. The Growth AUM has increased by 32% YoY, and PAT has increased by 67% YoY. The company's asset quality remains stable, with GNPA at 2.4% and Growth business credit cost at 1.6%. The company has also highlighted the impact of AI across five key business areas, with a 16% increase in token volume and 3.2% increase in total SLM and LLM token usage.

Texmaco Rail & Engineering Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue of ₹75,292.34 crore and profit before tax of ₹4,413.60 crore.

Raymond Ltd has announced a conference call to discuss its financial performance for the first quarter ended June 30, 2026. The call is scheduled for August 7, 2026, at 5:00 p.m. (IST).

Latent View Analytics Limited has published a copy of newspaper advertisements for financial results for the quarter ended June 30, 2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Glenmark Pharmaceuticals has uploaded the audio recording of its Q1 FY 2026-27 earnings call on its website.

Tata Chemicals Limited has announced the transcript of its Q1FY27 earnings conference call, highlighting the company's operational highlights and demand scenario across its three segments: Living, Industry, and Farm Essentials. The company has made a significant accounting change, renaming its segments to align with its business operations.

Restaurant Brands Asia Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has also approved an investment in its subsidiary PT Sari Burger Indonesia.

Computer Age Management Services Ltd (CAMS) has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results show an 18.3% YoY growth in EBITDA to ₹183 Cr, with an EBITDA margin expansion of 270 basis points to 46.4%. Operating revenue grew 11.5% YoY to ₹395 Cr, and profit after tax (PAT) grew 17.3% YoY to ₹128 Cr. Mutual fund asset-based revenue grew 11.2% YoY, and non-MF businesses grew 28.4% YoY. CAMS's AuM grew 14.8% YoY to a record ₹56 Lakh Cr, with the SIF segment gaining traction and equity AuM growing 17.6% YoY to ₹31.4 lakh crore.

Restaurant Brands Asia Ltd has announced the outcome of its Board meeting held on August 03, 2026. The Board has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and also approved an investment in PT Sari Burger Indonesia by way of acquisition of redeemable cumulative non-convertible preference shares.

Manugraph India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 to consider and approve Unaudited Financial Results.

Noida Toll Bridge Company Ltd has announced the outcome of its Board Meeting held on August 3, 2026. The Board has approved the standalone and consolidated unaudited financial results for the quarter and three months ended June 30, 2026, along with a limited review report. The Board has also approved the appointment of Mr. Balvinder Singh as an Independent Director for a term of 5 years, subject to shareholder approval. Additionally, the Board has approved the rectification of the fee of the Statutory Auditor, subject to shareholder approval.

TCPL Packaging Ltd will host a conference call on August 12, 2026, to discuss its Q1 FY2027 results, which will be declared on August 11, 2026.

Raymond Limited has announced a conference call to discuss its financial performance for the first quarter ended June 30, 2026, scheduled for August 7, 2026.

Nexus Select Trust has informed the Exchange regarding Disclosure of material issue, announcing the Unaudited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter June 30, 2026, and declaring distributions of ₹369.96 Crores / ₹2.442 per Unit for the quarter ended June 30, 2026.

Dollar Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve un-audited financial results for the quarter ended 30th June, 2026.

Latent View Analytics Ltd has published a newspaper advertisement for its financial results for the quarter ended June 30, 2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Peninsula Land Ltd has announced the details of its 154th Annual General Meeting to be held through Video Conference (VC)/ Other Audio Visual Means (OAVM). The meeting will be held on August 3, 2022, and the company has requested shareholders to take necessary action.

Kaya Limited has submitted its financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditor. The company has also made several appointments, including a new Company Secretary and Compliance Officer, a Vice President and HR-Head, and a Managing Director. Additionally, the Board has deferred the agenda item for raising equity shares and debt securities until further notice.

Kansai Nerolac Paints Ltd has announced its unaudited financial results for the quarter ended 30th June, 2026. The company's board of directors has approved the results, which include a limited review report from the statutory auditors. The results will be published in newspapers in the prescribed formats.

GlaxoSmithKline Pharmaceuticals Ltd announced its Q1FY27 financial results, with revenue at INR 924 crores, up 15% Y-o-Y, and Profit After Tax (PAT) increasing by 24% to INR 253 crores. The company's General Medicines portfolio grew strongly, with key promoted brands outperforming the market. The Vaccines business also grew, driven by continued leadership in the self-pay private paediatric vaccines market and stronger endorsement from the healthcare professional community.